AN
ANN.AU Ansell Ltd
- Market cap
- AUD 6.39B
- P/E
- 21.2x
- P/B
- 2.27x
- ROE
- 10.7%
- Dividend yield
- 2.55%
- Fundamental score
- 3.0/5
Ratios use the latest price and the fiscal year ending Jun 2026.
Is ANN.AU undervalued?
Graham numberANN.AU trades 46.2% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Ansell Ltd fundamental analysis
15 of 22 checks passedROE 1/2
Moderate return on equity (10.7%), between 10% and 20%.
ROA 1/1
Return on assets (6.3%) is above the industry median (-35.3%).
Profit Consistency 2/2
Profitable for 10 consecutive years.
Earnings Growth 5Y 0/1
Earnings per share did not grow over the past 5 years.
Earnings Acceleration 1/1
Last year's EPS growth (113.3%) is above the 5-year average (-4.8% a year).
Earnings Growth vs Industry 1/1
Last year's EPS growth (113.3%) is above the industry median (24.9%).
Revenue Growth 1/2
Revenue grew 9.7% a year over the past 3 years.
Short-term Liquidity 1/1
Current assets cover short-term liabilities.
Long-term Liabilities 1/1
Current assets cover long-term liabilities.
Debt to Equity 2/2
Low debt to equity (38.0%), 40% or less.
Debt Trend 0/1
Debt to equity has risen over the past 5 years.
Debt Coverage 1/1
Operating cash flow covers 20% of total debt.
Interest Coverage 1/1
EBIT is 7.4x against interest expense, well covered.
PE vs Market 0/1
PE (21.2x) is above the market median (15.0x).
PE vs Industry 1/1
PE (21.2x) is below the industry median (36.4x).
PBV 1/1
Price to book (2.3x) is below the industry median (4.0x).
Graham Number 0/1
The price is above the Graham number (PE x PB = 48.1, limit 22.5).
PEG 0/1
PEG needs positive PE and positive 5-year earnings growth.
Dividend Yield 0/2
Dividend yield (1.8%) is in the bottom 25% of dividend payers in the market.
Dividend Stability 0/2
Dividends were not paid steadily for the past 5 years.
Dividend Growth 1/1
Dividends paid grew over the past 5 years.
Payout Ratio 1/1
Payout ratio is 37.8%, covered by earnings.
Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score
Ansell Ltd stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Ansell Ltd
Ansell Limited designs, sources, develops, manufactures, distributes, and sells hand and body protection solutions in the Asia Pacific, Europe, the Middle East, Africa, Latin America, the Caribbean, and North America. It operates through two segments: Healthcare and Industrial. The Healthcare segment manufactures and markets solutions, including surgical gloves, operating room consumables, single-use and examination gloves, and clean and sterile gloves and garments, as well …
Full company profileAnsell Ltd financial statements
Ansell Ltd annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | 1.37B | 1.49B | 1.50B | 1.61B | 2.03B | 1.95B | 1.66B | 1.62B | 2.00B | 2.19B |
| Gross Profit | 541M | 583M | 584M | 633M | 807M | 625M | 617M | 625M | 825M | 906M |
| Operating Income | 162M | 166M | 191M | 223M | 330M | 237M | 211M | 179M | 109M | 343M |
| EBITDA | 224M | 208M | 203M | 281M | 403M | 299M | 276M | 202M | 257M | 425M |
| Net Income | 148M | 484M | 112M | 159M | 247M | 159M | 148M | 76.5M | 102M | 213M |
| EPS | 0.99 | 3.32 | 0.81 | 1.20 | 1.90 | 1.24 | 1.17 | 0.59 | 0.70 | 1.48 |
| Balance Sheet | ||||||||||
| Total Assets | 2.45B | 2.51B | 2.37B | 2.45B | 2.74B | 2.51B | 2.52B | 3.24B | 3.32B | 3.39B |
| Total Liabilities | 1.22B | 969M | 963M | 1.05B | 1.17B | 949M | 913M | 1.33B | 1.34B | 1.37B |
| Shareholders' Equity | 1.21B | 1.53B | 1.39B | 1.39B | 1.55B | 1.54B | 1.60B | 1.89B | 1.96B | 1.99B |
| Cash & Short-term Investments | 321M | 590M | 396M | 412M | 240M | 206M | 159M | 912M | 238M | 249M |
| Total Debt | 720M | 550M | 545M | 578M | 516M | 486M | 494M | 857M | 806M | 756M |
| Cash Flow | ||||||||||
| Operating Cash Flow | 198M | 154M | 189M | 287M | 173M | 222M | 181M | 272M | 239M | 355M |
| Capital Expenditure | 51.8M | 43.4M | 42.6M | 62.6M | 83.2M | 64.0M | 66.3M | 62.8M | 69.3M | 50.1M |
| Free Cash Flow | 146M | 88.6M | 130M | 218M | 72.2M | 128M | 95.4M | 209M | 170M | 305M |
| Ratios | ||||||||||
| ROE | 12.2% | 31.7% | 8.0% | 11.4% | 15.9% | 10.3% | 9.3% | 4.0% | 5.2% | 10.7% |
| ROA | 6.0% | 19.3% | 4.7% | 6.5% | 9.0% | 6.3% | 5.9% | 2.4% | 3.1% | 6.3% |
| Net Profit Margin | 10.7% | 32.5% | 7.5% | 9.8% | 12.2% | 8.1% | 9.0% | 4.7% | 5.1% | 9.7% |
| Debt to Equity | 0.60x | 0.36x | 0.39x | 0.41x | 0.33x | 0.31x | 0.31x | 0.45x | 0.41x | 0.38x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Ansell Ltd dividends
- Dividend yield
- 2.55%
- Forward dividend
- 1.16 AUD
- Payout ratio
- 37.8%
- Ex-dividend date
- Aug 31, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2026 | USD 80.5M | 0.56 | 37.8% |
| 2025 | USD 63.7M | 0.44 | 62.7% |
| 2024 | USD 53.2M | 0.41 | 69.5% |
| 2023 | USD 62.9M | 0.49 | 42.4% |
| 2022 | USD 86.8M | 0.68 | 54.7% |
| 2021 | USD 77.3M | 0.59 | 31.3% |
| 2020 | USD 63.3M | 0.48 | 39.9% |
| 2019 | USD 58.3M | 0.42 | 52.2% |
| 2018 | USD 58.0M | 0.40 | 12.0% |
| 2017 | USD 61.2M | 0.41 | 41.4% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 1:5 on Apr 15, 2002.
Who owns Ansell Ltd
- Insiders 1.39%
- Institutions 65.77%
- Public & others 32.84%
- Shares outstanding 141M
- Free float 138M
Top funds holding ANN.AU
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| Vanguard International Stock Index-Total Intl Stock Indx | 1.99M | 1.55% | - | Oct 2020 |
| Invesco Oppenheimer International Small-Mid Company Fund | 1.78M | 1.39% | - | Jan 2021 |
| Columbia Fds Var Ser Tr II-Columbia Var Port-Overseas Core Fd | 1.16M | 0.90% | - | Dec 2020 |
| MFS International New Discovery Fund | 1.06M | 0.83% | - | Dec 2020 |
| Vanguard Tax Managed Fund-Vanguard Developed Markets Index Fund | 820K | 0.64% | - | Dec 2020 |
| Blackrock Enhanced International Dividend Trust | 614K | 0.48% | - | Dec 2020 |
| iShares Core MSCI EAFE ETF | 613K | 0.48% | - | Feb 2021 |
| Old Westbury Small & Mid Cap Strategies Fund | 587K | 0.46% | - | Jan 2021 |
| iShares MSCI EAFE Small Cap ETF | 558K | 0.43% | - | Feb 2021 |
| DFA International Small Cap Value Portfolio | 542K | 0.42% | - | Jan 2021 |
Ansell Ltd company profile
- Company name
- Ansell Ltd
- Ticker
- ANN.AU
- ISIN
- AU000000ANN9
- Exchange
- Australian Securities Exchange
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Employees
- 15,000
- Fiscal year end
- June
- Address
- 678 Victoria Street, Richmond, VIC, Australia, 3121
- Phone
- 61 1 9270 7222
- Website
- ansell.com
About Ansell Ltd
Ansell Limited designs, sources, develops, manufactures, distributes, and sells hand and body protection solutions in the Asia Pacific, Europe, the Middle East, Africa, Latin America, the Caribbean, and North America. It operates through two segments: Healthcare and Industrial. The Healthcare segment manufactures and markets solutions, including surgical gloves, operating room consumables, single-use and examination gloves, and clean and sterile gloves and garments, as well as consumables for hospitals, surgical centers, dental surgeries, veterinary clinics, first responders, manufacturers, auto repair shops, chemical plants, laboratories, and life sciences and pharmaceutical companies. The Industrial segment manufactures and markets hand and chemical protective clothing solutions for various industrial applications, including automotive, chemical, metal fabrication, machinery and equipment, food, construction, mining, oil and gas, utilities, logistics, and first responders. It sells provides its products under ActivArmr, AlphaTec, BioClean, EDGE, ENCORE, GAMMEX, HyFlex, Kimtech, KleenGuard, MICROFLEX, MICRO-TOUCH, RINGERS, SANDEL, and TouchNTuff brands. The company was formerly known as Pacific Dunlop Limited and changed its name to Ansell Limited in 2002. Ansell Limited was founded in 1893 and is based in Richmond, Australia.
Ansell Ltd management
10- Ms. Nathalie Ahlstrom M.Sc., TechMD, CEO & Director · born 1974
- Mr. Erik van den EndenChief Financial Officer · born 1978
- Mr. John MarsdenChief Operations & Supply Chain Officer
- Ms. Deanna JohnstonChief Information Officer
- Mr. Michael EvansSenior Director of Investor Relations and Corporate M&A
- Mr. Philippe H. RommelChief Legal Officer
- Mr. Rob HughesChief Product & Marketing Officer
- Ms. Charlotte DollChief Human Resource Officer
- Mr. Augusto M. AccorsiChief Commercial Officer of EMEA & APAC
- Mr. Sean P. SweeneyChief Commercial Officer of Americas